Welcome to a new episode of our podcast.

Marisa Martínez interviewed Rodolfo Bellinzoni from Biogenesis Bago to explore the available tools for the prevention and control of an FMD emergency. Learn more about the impact cost, the level of investment required to control an outbreak, and some of the most effective tools for prevention and preparedness.

Marisa Martínez is a Doctor in Veterinary Medicine, and graduated in 2008 from the Universidad del Salvador, Veterinary School, in Argentina.

She worked on a dairy farm as Milk Quality Solution Manager in DeLaval from 2010 to 2012. Marisa joined Biogenesis Bagó in 2012, as Dairy Technical Service. Later on, as part of the Innovation

Department, she developed intramammary products that were launched to the market in 2016. From 2019, she was Technical Department Manager, and in 2022, became Product Manager for FMD and Biosecurity.

Since 2012, she is an active Member of the Honorable Board of Directors of APROCAL, a non-profit organization that works towards milk and dairy products quality in Argentina, and from 2015 to 2020 was its President. She has a Certification in Biosecurity Audits by Biocheck, from Ghent University and holds several publications at renowned congresses, both on dairy and FMD.

Rodolfo Bellinzoni is a Veterinary Doctor, who graduated from the Faculty of Veterinary Sciences of the Universidad Nacional del Centro de la Provincia de Buenos. He then obtained his Ph.D. degree and did postdoctoral training in Molecular Virology at Baylor College of Medicine in Houston, Texas, USA.

He joined Biogénesis Bagó in 1990 as R&D Manager and later, in 2000, he took the position of Director of Industrial Operations.

In parallel to his work in the company, between 2010 and 2014 he was the Director of Operations of Sinergium Biotech, where he managed technology transfer processes for the manufacture of influenza and pneumococcal vaccines in Argentina.

For Biogénesis Bagó, he led the design, engineering, construction, and technology transfer processes for the foot-and-mouth disease vaccine production plant that the company developed in Yangling, China.

From 2019, he was Director of Industrial Operations and Innovation for Biogénesis Bagó. His achievements for the company include leading the licensing process by which Biogénesis Bagó achieved supplier status with the Foot-and-Mouth Disease Antigen and Vaccine Bank of the USA, Canada, and Mexico and the National Animal Vaccine and Veterinary Countermeasure Bank (NAVVCB) of the United States Department of Agriculture (USDA).

In 2017, he became a full member of the Argentine National Academy of Agronomy and Veterinary Science for his main contribution to the control of foot-and-mouth disease.

**This podcast is part of a series linked to the Open Session of the EuFMD and does not intend to endorse any of the products mentioned.

The contents are the sole responsibility of the presenters and can in no way be taken to reflect the views of the EuFMD and its partners.**